Therapeutic screen for DNA damage in A-T patient derived motor neurons.

Awardee: Edward Gilmore

Institution: Case Western Reserve University School of Medicine

Award Amount: $87,164

Funding Period: February 1, 2019 - January 31, 2020

Previous
Previous

Biomarker correlates of neurocognitive outcomes in the cerebrospinal fluid in MPS I

Next
Next

Pharmacological, histological and metabolic analyses of a new drug candidate for APBD